GO
Loading...

Lightning Round: Huntsman, Amazon.com, Windstream and More

Synovus Financial : The Mad Money host sees a buying opportunity right now, being as shares of this Georgia-based financial institution are trading under $3.

Keryx Biopharmaceuticals : Cramer is bullish toward this biopharmaceutical company, but only as a speculative play.

Cellcom Israel : The Mad Money host is going to research this company before making a call.

Huntsman : “This company has gone from bad to good to great,” Cramer said. “I’m a buyer of Huntsman.”

Amazon.com : While Cramer likes this company for the long-term, he thinks it is too risky right now and praised Apple as an alternative.

Ashland : Last year was the time to buy Ashland, Cramer said. The share price is now too high.

Palm : Cramer does not like this technology company.

Windstream : “Windsteam is a buy,” Cramer said. “Everyone keeps worrying about the dividend. Stop worrying.”

JD Uniphase : Cramer likes JDSU.







Cramer’s charitable trust owns Apple.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book